Family Office of America, Inc. (FOFA): Operating Cash Flow
-$262.2K
Year ended 2025-12-31
$195.5K
Trailing 12 months to 2026-06-30
| Period ended | Operating Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$262.2K | n/m | 2026-04-16, From 2025-01-01 |
| 2024-12-31 | -$89.4K | n/m | 2026-04-16, From 2024-01-01 |
| 2023-12-31 | -$76.5K | n/m | 2025-03-10, From 2023-01-01 |
| 2022-12-31 | -$558.4K | n/m | 2024-07-18, From 2022-01-01 |
| 2021-12-31 | -$792.8K | n/a | 2023-04-24, From 2021-01-01 |
Operating Cash Flow at similar companies
| Company | Year ended | Operating Cash Flow | Change YoY |
|---|---|---|---|
| Family Office of America, Inc. (FOFA) | 2025-12-31 | -$262.2K | n/m |
| QTREX Quantum Ltd. (QTEX) | 2025-12-31 | -$9.86M | n/m |
| Pulse Biosciences, Inc. (PLSE) | 2025-12-31 | -$54.12M | n/m |
| Co-Diagnostics, Inc. (CODX) | 2025-12-31 | -$29.14M | n/m |
| Harvard Apparatus Regenerative Technology, Inc. (HRGN) | 2025-12-31 | -$3.83M | n/m |
| Vivos Inc (RDGL) | 2025-12-31 | -$2.06M | n/m |
| Catheter Precision, Inc. (VTAK) | 2025-12-31 | -$8.30M | n/m |
| Sintx Technologies, Inc. (SINT) | 2025-12-31 | -$8.57M | n/m |
| RenovoRx, Inc. (RNXT) | 2025-12-31 | -$10.97M | n/m |
Compare FOFA, QTEX, PLSE, CODX side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗